Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HFVI-guided remifentanil vs standard care in lower extremity arthroplasty
jRCTs062240013Active, not recruiting
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of remifentanil in osteoarthritis (OA) (2 arms). Primary endpoint: Intraoperative remifentanil consumption. Started Jun 2024; status: active, not recruiting.
02
Drugs
remifentanil
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on jRCTs062240013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs062240013.